X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3106) 3106
Book Chapter (22) 22
Publication (16) 16
Conference Proceeding (4) 4
Magazine Article (3) 3
Book Review (1) 1
Dissertation (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prasugrel (2294) 2294
humans (1984) 1984
clopidogrel (1977) 1977
index medicus (1912) 1912
ticagrelor (1145) 1145
cardiac & cardiovascular systems (1114) 1114
ticlopidine - analogs & derivatives (1049) 1049
male (1008) 1008
percutaneous coronary intervention (980) 980
platelet aggregation inhibitors - therapeutic use (926) 926
female (919) 919
prasugrel hydrochloride (868) 868
middle aged (777) 777
aged (704) 704
aspirin (698) 698
acute coronary syndromes (692) 692
treatment outcome (638) 638
ticlopidine - therapeutic use (598) 598
platelet aggregation inhibitors - adverse effects (555) 555
acute coronary syndrome (541) 541
platelet aggregation inhibitors - administration & dosage (534) 534
acute coronary syndrome - drug therapy (499) 499
antiplatelet therapy (479) 479
pharmacology & pharmacy (469) 469
adenosine - analogs & derivatives (455) 455
thiophenes - therapeutic use (455) 455
piperazines - therapeutic use (453) 453
abridged index medicus (389) 389
peripheral vascular disease (388) 388
hematology (368) 368
risk factors (364) 364
intervention (360) 360
ticlopidine - administration & dosage (351) 351
purinergic p2y receptor antagonists - therapeutic use (345) 345
platelet inhibition (341) 341
inhibition (334) 334
coronary heart disease (332) 332
ticlopidine - adverse effects (332) 332
myocardial-infarction (330) 330
blood platelets - drug effects (315) 315
cardiovascular (312) 312
hemorrhage - chemically induced (310) 310
platelet aggregation - drug effects (310) 310
platelet aggregation inhibitors - pharmacology (310) 310
blood platelets (308) 308
outcomes (297) 297
thrombosis (296) 296
cardiac patients (289) 289
aggregation (288) 288
adenosine - therapeutic use (287) 287
myocardial infarction (287) 287
elevation myocardial-infarction (283) 283
heart attacks (278) 278
platelet reactivity (270) 270
drug therapy, combination (265) 265
time factors (265) 265
care and treatment (260) 260
cardiology (250) 250
drug therapy (250) 250
piperazines - administration & dosage (248) 248
thiophenes - administration & dosage (246) 246
therapy (245) 245
piperazines - adverse effects (242) 242
thiophenes - adverse effects (242) 242
double-blind (240) 240
stent thrombosis (239) 239
stents (237) 237
prasugrel hydrochloride - therapeutic use (236) 236
trial (236) 236
purinergic p2y receptor antagonists - administration & dosage (235) 235
platelet function tests (232) 232
prospective studies (227) 227
aspirin - therapeutic use (225) 225
mortality (221) 221
medicine, general & internal (211) 211
platelets (209) 209
purinergic p2y receptor antagonists - adverse effects (206) 206
cangrelor (205) 205
acute coronary syndrome - therapy (204) 204
adult (204) 204
myocardial infarction - drug therapy (195) 195
piperazines - pharmacology (193) 193
transluminal angioplasty (190) 190
thiophenes - pharmacology (188) 188
platelet aggregation inhibitors - pharmacokinetics (186) 186
bleeding (185) 185
reactivity (185) 185
ticlopidine - pharmacology (181) 181
dual antiplatelet therapy (180) 180
analysis (178) 178
cardiovascular disease (177) 177
prasugrel hydrochloride - administration & dosage (176) 176
percutaneous coronary intervention - adverse effects (174) 174
cardiovascular diseases (173) 173
pharmacokinetics (171) 171
acute myocardial-infarction (170) 170
blood platelets - metabolism (169) 169
dose-response relationship, drug (169) 169
risk (169) 169
active metabolite (167) 167
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2936) 2936
German (68) 68
French (43) 43
Spanish (30) 30
Japanese (23) 23
Russian (19) 19
Polish (16) 16
Italian (14) 14
Czech (11) 11
Turkish (10) 10
Portuguese (3) 3
Korean (2) 2
Chinese (1) 1
Danish (1) 1
Finnish (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European heart journal, ISSN 1522-9645, 2017, Volume 38, Issue 41, pp. 3070 - 3078
Journal Article
Clinical research in cardiology, ISSN 1861-0692, 2015, Volume 105, Issue 4, pp. 349 - 355
Morphine decreases the concentrations and effects of clopidogrel, which could lead to treatment failure in myocardial infarction.To clarify whether more potent... 
Prasugrel | Medicine & Public Health | Drug interactions | Morphine | Platelet function tests | Cardiology | Vasodilator-stimulated phosphoprotein | MORTALITY | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | PHOSPHORYLATION | REPERFUSION | ACUTE CORONARY SYNDROMES | CLOPIDOGREL | PLATELET INHIBITION | INTERVENTION | ACTIVE METABOLITE | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Male | Purinergic P2Y Receptor Antagonists - blood | Drug Monitoring - methods | Healthy Volunteers | Platelet Aggregation Inhibitors - blood | Young Adult | Purinergic P2Y Receptor Antagonists - adverse effects | Tandem Mass Spectrometry | Austria | Analgesics, Opioid - adverse effects | Drug Interactions | Biotransformation | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Chromatography, Liquid | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Prasugrel Hydrochloride - pharmacokinetics | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Risk Assessment | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Prasugrel Hydrochloride - adverse effects | Cross-Over Studies | Analgesics, Opioid - administration & dosage | Morphine - administration & dosage | Morphine - adverse effects | Prasugrel Hydrochloride - blood | Medical colleges | Metabolites | Vasodilators | Clinical trials | Liquid chromatography | Mass spectrometry | Original Paper
Journal Article
European heart journal, ISSN 1522-9645, 2009, Volume 30, Issue 16, pp. 1964 - 1977
Currently, clopidogrel is recommended for treatment of patients with acute coronary syndrome and/or percutaneous coronary intervention. However, the delayed... 
Prasugrel | Clopidogrel | Thienopyridine | Cangrelor | Ticagrelor | Purinoceptor P2Y
Journal Article
Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue 21, pp. 1603 - 1612
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 2018, Volume 11, Issue 2, pp. 181 - 191
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 7, pp. 625 - 635
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 03/2008, Volume 28, Issue 3, pp. s33 - s38
Journal Article
Thrombosis Research, ISSN 0049-3848, 2016, Volume 143, pp. 141 - 148
Abstract Background The immediate administration of oral antiplatelet therapy in the form of aspirin plus a P2Y12 inhibitor is the universally recognised... 
Hematology, Oncology and Palliative Medicine | Prasugrel | P2Y12 inhibitors | Aspirin | ST elevation myocardial infarction | Platelet function assays | Primary percutaneous coronary intervention | STEMI | Clopidogrel | Ticagrelor | Inhibition of platelet activity (IPA) | MORTALITY | METAANALYSIS | PRIMARY PCI | ANTIPLATELET THERAPY | PERCUTANEOUS CORONARY INTERVENTION | TO-BALLOON TIME | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | PLATELET REACTIVITY | Prasugrel Hydrochloride - pharmacology | Adenosine - pharmacokinetics | Purinergic P2Y Receptor Antagonists - administration & dosage | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Adenosine - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Ticlopidine - administration & dosage | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Platelet Aggregation Inhibitors - therapeutic use | Prasugrel Hydrochloride - pharmacokinetics | Purinergic P2Y Receptor Antagonists - therapeutic use | Myocardial Infarction - surgery | Purinergic P2Y Receptor Antagonists - pharmacology | Administration, Oral | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Adenosine - pharmacology | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Prasugrel Hydrochloride - therapeutic use | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Percutaneous Coronary Intervention | Heart attack
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2017, Volume 117, Issue 8, pp. 1582 - 1587
Journal Article